A model for predicting celiac disease among undiagnosed subjects established with data from the HUNT4 study

Celiac disease (CeD) is an immune mediated disorder with substantial underdiagnosis, particularly in adults with non-specific symptoms. Universal population screening remains under debate due to cost-effectiveness and potential quality-of-life implications. Clinical prediction tools aid clinicians in identifying individuals who might benefit from targeted screening. Using data from 52,000 adults in the fourth population-based Trøndelag Health Study (HUNT4) in Norway, we developed and internally validated a non-diagnostic prediction model for previously undiagnosed CeD. The model incorporated predictors spanning genetics, lifestyle, symptoms, comorbidity, and biomarkers. Elastic-net logistic regression with nested cross-validation was chosen due to the low disease prevalence and imbalanced case-control distribution. Model performance was assessed by the area under the receiver operating characteristic curve, area under precision-recall curve, and calibration plots. Clinical utility was evaluated at different risk thresholds. Among 465 newly diagnosed cases and 51,515 controls, polygenic risk score emerged as the strongest predictor for CeD, alongside diabetic history, kidney function, chronic discomfort, and perceived health status. The model achieved high discrimination (84%) and good calibration (0.009). The model outperformed universal population screening by detecting more cases, especially when the predicted risk was less than 2%. Increasing sample prevalence for sensitivity analysis, revealed that the model was better in population scenarios compared to high-risk/high-prevalence scenarios. The multifactorial model demonstrated strong potential for guiding targeted screening for CeD, especially in low-prevalence, true population-based settings. While not a diagnostic tool, it may support clinical decision-making by identifying individuals at elevated risk. External validation and cost-effectiveness studies are needed before it can be implemented in primary care.

Authors

Institutions

Publication Details

Journal
BMC Gastroenterology
Published
2026-04-16
DOI
https://doi.org/10.1186/s12876-026-04837-y
Primary Topic
Celiac Disease Research and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A model for predicting celiac disease among undiagnosed subjects established with data from the HUNT4 study

Iris H. Jonkers, Sebo Withoff, Rebecka Hjort, LM. Sollid et al.
BMC Gastroenterology
Celiac Disease Research and Management
article

A model for predicting celiac disease among undiagnosed subjects established with data from the HUNT4 study

Iris H. Jonkers, Sebo Withoff, Rebecka Hjort, LM. Sollid, M. Alam, Kristian Hveem, Eivind Ness-Jensen, Knut E. A. Lundin
article en

Abstract

Celiac disease (CeD) is an immune mediated disorder with substantial underdiagnosis, particularly in adults with non-specific symptoms. Universal population screening remains under debate due to cost-effectiveness and potential quality-of-life implications. Clinical prediction tools aid clinicians in identifying individuals who might benefit from targeted screening. Using data from 52,000 adults in the fourth population-based Trøndelag Health Study (HUNT4) in Norway, we developed and internally validated a non-diagnostic prediction model for previously undiagnosed CeD. The model incorporated predictors spanning genetics, lifestyle, symptoms, comorbidity, and biomarkers. Elastic-net logistic regression with nested cross-validation was chosen due to the low disease prevalence and imbalanced case-control distribution. Model performance was assessed by the area under the receiver operating characteristic curve, area under precision-recall curve, and calibration plots. Clinical utility was evaluated at different risk thresholds. Among 465 newly diagnosed cases and 51,515 controls, polygenic risk score emerged as the strongest predictor for CeD, alongside diabetic history, kidney function, chronic discomfort, and perceived health status. The model achieved high discrimination (84%) and good calibration (0.009). The model outperformed universal population screening by detecting more cases, especially when the predicted risk was less than 2%. Increasing sample prevalence for sensitivity analysis, revealed that the model was better in population scenarios compared to high-risk/high-prevalence scenarios. The multifactorial model demonstrated strong potential for guiding targeted screening for CeD, especially in low-prevalence, true population-based settings. While not a diagnostic tool, it may support clinical decision-making by identifying individuals at elevated risk. External validation and cost-effectiveness studies are needed before it can be implemented in primary care.

BMC Gastroenterology
Oslo University Hospital (NO), University Medical Center Groningen (NL), Karolinska University Hospital (SE), University of Groningen (NL), University of Oslo (NO), Norwegian University of Science and Technology (NO), Levanger Hospital (NO), Karolinska Institutet (SE), St Olav's University Hospital (NO)
Peace, Justice and strong institutions
Openalex Percentile: Top 5%
Celiac Disease Research and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.